Cornerstone Market Intelligence independently selects these stories without issuer payment or pre-publication approval. Reports identify the source material used, the publication date and the responsible writer and editor.
149 independent articles. Every story identifies its source and commercial status.
Life SciencesIndependent editorialBioVaxys Technology Corp. reported positive findings from a Phase 2 clinical study evaluating maveropepimut-S (MVP-S) with pembrolizumab and low-dose cyclophosphamide in patients with advanced or metastatic bladder cancer.
Read full coverage →
Mining & Critical MineralsIndependent editorialApollo Silver closed a $12.5 million second and final tranche at $5.00 per unit, taking total gross proceeds from the financing to $27.5 million.
Read full coverage →
Mining & Critical MineralsIndependent editorialCleanTech appointed James Rodriguez de Castro as an advisor, citing more than 15 years of fluorspar experience across project development, supply chains and finance.
Read full coverage →
Life SciencesIndependent editorialBioVaxys reported positive preliminary results from the investigator-initiated Phase 1B/2 PESCO study in recurrent epithelial ovarian cancer.
Read full coverage →
Mining & Critical MineralsIndependent editorialRio Silver began the Peruvian regulatory process needed for physical access and staged underground entry at the Maria Norte silver project, engaging mining and explosives authorities.
Read full coverage →